Moreover, we confirmed the stronger CCL16 immunostaining in 8 pairs of fresh breast cancer tissue and adjacent normal breast tissue by qRT-PCR and Western blot (Figure 1F-G). This evidence concerns the gene CCL16 and breast cancer.